Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Mebiol is a Japanese biotechnology company specializing in the development of advanced polymer technologies for agriculture and medicine. The company is best known for its proprietary Thermoreversible Gelation Polymer (TGP), marketed as Mebiol Gel, which transitions between liquid and gel states based on temperature. This hydrogel is widely used in regenerative medicine, 3D cell culture, and drug delivery systems due to its biocompatibility and ease of handling. Additionally, Mebiol has pioneered "Imec" film farming, a sustainable agricultural technology that uses hydrogel membranes to grow crops with significantly less water and soil. The company's innovations bridge the gap between material science and life sciences, providing solutions for global challenges in food security and healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Mebiol.